Literature DB >> 22466513

Quantitative evaluation of MR perfusion imaging using blood pool contrast agent in subjects without pulmonary diseases and in patients with pulmonary embolism.

Andreas Hansch1, Peter Kohlmann, Uta Hinneburg, Joachim Boettcher, Ansgar Malich, Gunter Wolf, Hendrik Laue, Alexander Pfeil.   

Abstract

OBJECTIVE: To assess the feasibility of time-resolved parallel three-dimensional magnetic resonance imaging (MRI) for quantitative analysis of pulmonary perfusion using a blood pool contrast agent.
METHODS: Quantitative perfusion analysis was performed using novel software to assess pulmonary blood flow (PBF), pulmonary blood volume (PBV) and mean transit time (MTT) in a quantitative manner.
RESULTS: The evaluation of lung perfusion in the normal subjects showed an increase of PBF, PBV ventrally to dorsally (gravitational direction), and the highest values at the upper lobe, with a decrease to the middle and lower lobe (isogravitational direction). MTT showed no relevant changes in either the gravitational or isogravitational directions. In comparison with normally perfused lung areas (in diseased patients), the pulmonary embolism (PE) regions showed a significantly lower mean PBF (20 ± 0.6 ml/100 ml/min, normal region 94 ± 1 ml/100 ml/min; P < 0.001), mean PBV (2 ± 0.1 ml/100 ml, normal region 9.8 ± 0.1 ml/100 ml; P < 0.001) and mean MTT (3.8 ± 0.1 s; normal region 6.3 ± 0.1; P < 0.001).
CONCLUSION: Our results demonstrate the feasibility of using time-resolved dynamic contrast-enhanced MRI to determine normal range and regional variation of pulmonary perfusion and perfusion deficits in patients with PE. KEY POINTS: • Recently introduced blood pool contrast agents improve MR evaluation of lung perfusion • Regional differences in lung perfusion indicating a gravitational and isogravitational dependency. • Focal areas of significantly decreased perfusion are detectable in pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466513     DOI: 10.1007/s00330-012-2428-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

Review 1.  Spiral CT angiography of the pulmonary circulation.

Authors:  M Remy-Jardin; J Remy
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

2.  Evaluation of regional pulmonary perfusion using ultrafast magnetic resonance imaging.

Authors:  D L Levin; Q Chen; M Zhang; R R Edelman; H Hatabu
Journal:  Magn Reson Med       Date:  2001-07       Impact factor: 4.668

Review 3.  Recent advances in magnetic resonance perfusion imaging of the lung.

Authors:  Hidemasa Uematsu; Yoshiharu Ohno; Hiroto Hatabu
Journal:  Top Magn Reson Imaging       Date:  2003-06

4.  Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.

Authors:  Alexander Pfeil; Stefan Betge; Guenther Poehlmann; Joachim Boettcher; Robert Drescher; Ansgar Malich; Gunter Wolf; Hans-Joachim Mentzel; Andreas Hansch
Journal:  Eur J Radiol       Date:  2011-02-23       Impact factor: 3.528

5.  Pulmonary perfusion and angiography: evaluation with breath-hold enhanced three-dimensional fast imaging steady-state precession MR imaging with short TR and TE.

Authors:  H Hatabu; J Gaa; D Kim; W Li; P V Prasad; R R Edelman
Journal:  AJR Am J Roentgenol       Date:  1996-09       Impact factor: 3.959

6.  Pulmonary ventilation and perfusion imaging with dual-energy CT.

Authors:  Sven F Thieme; Sandra Hoegl; Konstantin Nikolaou; Juergen Fisahn; Michael Irlbeck; Daniel Maxien; Maximilian F Reiser; Christoph R Becker; Thorsten R C Johnson
Journal:  Eur Radiol       Date:  2010-06-23       Impact factor: 5.315

7.  Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH.

Authors:  H Hatabu; J Gaa; D Kim; W Li; P V Prasad; R R Edelman
Journal:  Magn Reson Med       Date:  1996-10       Impact factor: 4.668

8.  MRI for short-term follow-up of acute pulmonary embolism. Assessment of thrombus appearance and pulmonary perfusion: a feasibility study.

Authors:  Alexander Kluge; Tibo Gerriets; Uwe Lange; George Bachman
Journal:  Eur Radiol       Date:  2005-05-13       Impact factor: 5.315

9.  Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent.

Authors:  Andreas Hansch; Stefan Betge; Gunther Poehlmann; Steffi Neumann; Pascal Baltzer; Alexander Pfeil; Matthias Waginger; Joachim Boettcher; Werner A Kaiser; Gunter Wolf; Hans-Joachim Mentzel
Journal:  Eur Radiol       Date:  2010-08-09       Impact factor: 5.315

10.  Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer.

Authors:  Yoshiharu Ohno; Hiroto Hatabu; Takanori Higashino; Daisuke Takenaka; Hirokazu Watanabe; Yoshihiro Nishimura; Masahiro Yoshimura; Kazuro Sugimura
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

View more
  3 in total

1.  Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study.

Authors:  Katja Hueper; Megha A Parikh; Martin R Prince; Christian Schoenfeld; Chia Liu; David A Bluemke; Stephen M Dashnaw; Thomas A Goldstein; Eric A Hoffman; Joao A Lima; Jan Skrok; Jie Zheng; R Graham Barr; Jens Vogel-Claussen
Journal:  Invest Radiol       Date:  2013-04       Impact factor: 6.016

Review 2.  From Early Morphometrics to Machine Learning-What Future for Cardiovascular Imaging of the Pulmonary Circulation?

Authors:  Deepa Gopalan; J Simon R Gibbs
Journal:  Diagnostics (Basel)       Date:  2020-11-25

3.  Value of Dual-energy Lung Perfusion Imaging Using a Dual-source CT System for the Pulmonary Embolism.

Authors:  Jinshan Zhang; Jing Cai; Shulan Liu; Xianmei Zhang
Journal:  Open Life Sci       Date:  2018-04-18       Impact factor: 0.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.